Literature DB >> 15546957

Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity.

Markus Munder1, Faustino Mollinedo, Jero Calafat, Javier Canchado, Cristina Gil-Lamaignere, José M Fuentes, Claudia Luckner, Gwendolyn Doschko, Germán Soler, Klaus Eichmann, Frank-Michael Müller, Anthony D Ho, Martin Goerner, Manuel Modolell.   

Abstract

The balance of arginine metabolism via nitric oxide synthase (NOS) or arginase is an important determinant of the inflammatory response of murine macrophages and dendritic cells. Here we analyzed the expression of the isoform arginase I in human myeloid cells. Using healthy donors and patients with arginase I deficiency, we found that in human leukocytes arginase I is constitutively expressed only in granulocytes and is not modulated by a variety of proinflammatory and anti-inflammatory stimuli in vitro. We demonstrate that arginase I is localized in azurophil granules of neutrophils and constitutes a novel antimicrobial effector pathway, likely through arginine depletion in the phagolysosome. Our findings demonstrate important differences between murine and human leukocytes with respect to regulation and function of arginine metabolism via arginase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15546957     DOI: 10.1182/blood-2004-07-2521

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  129 in total

1.  Arginase as a new concern in blood transfusion.

Authors:  Faustino Mollinedo; Miguel Angel Palomero-Rodríguez; Pilar Sánchez-Conde; Rósula García-Navas; Yolanda Laporta-Báez; Jesús de Vicente-Sánchez; Luis Suarez-Gonzalo
Journal:  Blood Transfus       Date:  2013-05-29       Impact factor: 3.443

2.  Arginase I levels are decreased in the plasma of pediatric patients with atopic dermatitis.

Authors:  Victoria Dimitriades; Paulo C Rodriguez; Jovanny Zabaleta; Augusto C Ochoa
Journal:  Ann Allergy Asthma Immunol       Date:  2014-07-11       Impact factor: 6.347

Review 3.  Obstacles and opportunities for understanding macrophage polarization.

Authors:  Peter J Murray; Thomas A Wynn
Journal:  J Leukoc Biol       Date:  2011-01-19       Impact factor: 4.962

4.  Hyperargininemia: a family with a novel mutation in an unexpected site.

Authors:  Y Haimi Cohen; R Bargal; M Zeigler; T Markus-Eidlitz; V Zuri; A Zeharia
Journal:  JIMD Rep       Date:  2011-12-21

5.  Arginase in parasitic infections: macrophage activation, immunosuppression, and intracellular signals.

Authors:  Cinthia C Stempin; Laura R Dulgerian; Vanina V Garrido; Fabio M Cerban
Journal:  J Biomed Biotechnol       Date:  2009-12-09

6.  A role for IL-18 in protective immunity against Mycobacterium tuberculosis.

Authors:  Bianca E Schneider; Daniel Korbel; Kristine Hagens; Markus Koch; Bärbel Raupach; Jana Enders; Stefan H E Kaufmann; Hans-Willi Mittrücker; Ulrich E Schaible
Journal:  Eur J Immunol       Date:  2010-02       Impact factor: 5.532

7.  The pattern of GPI-80 expression is a useful marker for unusual myeloid maturation in peripheral blood.

Authors:  Y Takeda; T Kato; H Ito; Y Kurota; A Yamagishi; T Sakurai; A Araki; H Nara; N Tsuchiya; H Asao
Journal:  Clin Exp Immunol       Date:  2016-10-04       Impact factor: 4.330

8.  The phenotype of murine wound macrophages.

Authors:  Jean M Daley; Samielle K Brancato; Alan A Thomay; Jonathan S Reichner; Jorge E Albina
Journal:  J Leukoc Biol       Date:  2010-01       Impact factor: 4.962

9.  Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasis.

Authors:  Manuel Modolell; Beak-San Choi; Robert O Ryan; Maggie Hancock; Richard G Titus; Tamrat Abebe; Asrat Hailu; Ingrid Müller; Matthew E Rogers; Charles R M Bangham; Markus Munder; Pascale Kropf
Journal:  PLoS Negl Trop Dis       Date:  2009-07-14

10.  Kinetic analysis of ex vivo human blood infection by Leishmania.

Authors:  Inmaculada Moreno; Mercedes Domínguez; Darío Cabañes; Carmen Aizpurua; Alfredo Toraño
Journal:  PLoS Negl Trop Dis       Date:  2010-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.